HeeJung Park

HeeJung Park is currently the Neuro Muscular Disease Business Unit lead at Biogen Korea, overseeing products such as Spinraza for Spinal Muscular Atrophy and ALS. Previously, HeeJung held various marketing roles, including Head of Marketing for Specialty Care at Mundipharma and Marketing Manager at GSK, where they managed portfolios in urology, rare diseases, and new asset launches. HeeJung began their career at Boehringer Ingelheim as a medical representative before transitioning to brand management in consumer healthcare. They earned a Bachelor's degree from 중앙대학교 in 2001.